ClinicalTrials.gg
RecruitingNCT06885788Updated Mar 25, 2025

Uterine Round Ligament Preservation Vs Resection in Laparoscopic Inguinal Hernia Repair in Women:A Multicenter,Stratified Randomized Controlled Trial

An interventional study of To remove the uterine uterine ligament in Inguinal Hernia, Laparoscopic Surgery and Randomized Controlled Trial, sponsored by Nanchong Central Hospital. Recruiting at 1 site in China. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-03-25.

Sponsored by Nanchong Central Hospital · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Sep 2024, registered Mar 2025).
  • Started Sep 2024; still recruiting 2 years 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
466
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

This study aims to compare the clinical effects of uterine round ligament preservation versus resection in laparoscopic inguinal hernia repair in women.The primary outcomes included Time required for patient surgery.The secondary outcomes included Inguinal hernia recurrence,quality of life assessment,Indicators of postoperative recovery,, et al.

02

Conditions studied

  • Inguinal Hernia
  • Laparoscopic Surgery
  • Randomized Controlled Trial

Browse trials for

03

In context

Hernia, Inguinal

543 studies on the registry are indexed under Hernia, Inguinal; 92 are open to participants now.

This study's planned enrollment of 466 is above the median of 90 across 395 interventional studies indexed under Hernia, Inguinal.

Browse Hernia, Inguinal studies →

Lead sponsor

Nanchong Central Hospital is the lead sponsor of 20 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ►Age : Female patients over 18 years of age without a childbearing requirement

    • Diagnosis and basis : Female patients diagnosed with Unilateral inguinal hernia.
    • agreed to participate in this study and signed the form.

Exclusion criteria

Exclusion Criteria:

  • ►Combined with severe heart, liver, kidney and other diseases.

    • pregnant or lactating women.
    • those with surgical .
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
466 participants (estimated)

Study arms

  • Experimental
    Patients with unilateral hernia who did not give birth,the uterine round ligament resection group

    Both groups underwent laparoscopic inguinal hernia repair,the resection group removed the uterine round ligament.(Patients with unilateral hernia who did not give birth)

    Procedure: To remove the uterine uterine ligament

  • No intervention
    Patients with unilateral hernia who did not give birth,the uterine round ligament preservation group

    Both groups underwent laparoscopic inguinal hernia repair,the preservation group retained the uterine round ligament.(Patients with unilateral hernia who did not give birth)

  • Experimental
    Patients with unilateral hernia who have given birth,the uterine round ligament resection group

    Both groups underwent laparoscopic inguinal hernia repair,the resection group removed the uterine round ligament.(Patients with unilateral hernia who have given birth)

    Procedure: To remove the uterine uterine ligament

  • No intervention
    Patients with unilateral hernia who have given birth,the uterine round ligament preservation group

    Both groups underwent laparoscopic inguinal hernia repair,the preservation group retained the uterine round ligament.(Patients with unilateral hernia who have given birth)

  • Experimental
    Patients with bilateral hernias who have given birth,the uterine round ligament resection group

    Both groups underwent laparoscopic inguinal hernia repair,the resection group removed the uterine round ligament.(Patients with bilateral hernias who have given birth)

    Procedure: To remove the uterine uterine ligament

  • No intervention
    Patients with bilateral hernias who have given birth,the uterine round ligament preservation group

    Both groups underwent laparoscopic inguinal hernia repair,the preservation group retained the uterine round ligament.(Patients with bilateral hernias who have given birth)

  • Experimental
    Patients with bilateral hernia who did not give birth,the uterine round ligament resection group

    Both groups underwent laparoscopic inguinal hernia repair,the resection group removed the uterine round ligament.(Patients with bilateral hernia who did not give birth)

    Procedure: To remove the uterine uterine ligament

  • No intervention
    Patients with bilateral hernia who did not give birth,the uterine round ligament preservation group

    Both groups underwent laparoscopic inguinal hernia repair,the preservation group retained the uterine round ligament.(Patients with bilateral hernia who did not give birth)

Interventions

  • ProcedureTo remove the uterine uterine ligament

    Both groups underwent laparoscopic inguinal hernia repair. The preservation group retained the uterine round ligament, while the resection group had it removed.

06

What researchers measure

Primary outcomes

  1. Time required for patient surgery

    Time required for patient surgery

    Time frame: 20-120minutes

Secondary outcomes

  1. Inguinal hernia recurrence

    the recurrence of inguinal hernia

    Time frame: 1 month, 3 months, 6 months,1year,2years,3years,6years

  2. Quality of life assessment

    Quality of life assessment:The international general quality of life scale (such as SF - 36, etc.) is used to evaluate the quality of life of patients at 3 months , 6months,1year,2years,3years and 6years after surgery.

    Time frame: 3 months,6months,1year,2years,3years,6years

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2024 (actual). Primary completion is estimated for Dec 2026, 27 months after the start.

Of 177 non-industry interventional studies with no phase under Hernia, Inguinal, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 35. This study's planned 27 months is above that.

Counting every sponsor, half of 186 studies reached it within 19 months; a quarter within 9 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 8, 2025
First posted
Mar 20, 2025
StartActual
Sep 20, 2024
Primary completionEst.
Dec 31, 2026
CompletionEst.
Mar 1, 2027
Last update
Mar 25, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 25, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06885788
Lead sponsor
Nanchong Central Hospital
Responsible party
Sponsor
First posted
Mar 20, 2025
Start date
Sep 20, 2024
Primary completion
Dec 31, 2026 (estimated)
Completion
Mar 1, 2027 (estimated)
Last update
Mar 25, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion